Tejara Capital LTD Portfolio Holdings

Tejara Capital LTD

  • $210 Billion
  • Q3 2024

Tejara Capital LTD has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $210 Billion distributed in 56 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $16.4B, Mereo Biopharma Group PLC with a value of $11.6B, Arcutis Biotherapeutics, Inc. with a value of $10.8B, Heron Therapeutics, Inc. with a value of $10.6B, and Scorpio Tankers Inc. with a value of $9.53B.

Examining the 13F form we can see an decrease of $65.2B in the current position value, from $275B to 210B.

Tejara Capital LTD is based out at London, X0

Below you can find more details about Tejara Capital LTD portfolio as well as his latest detailed transactions.

Portfolio value $210 Billion
Energy: $85.5 Billion
Healthcare: $83.2 Billion
Technology: $15.4 Billion
Communication Services: $2.63 Billion
Basic Materials: $2.58 Billion
Industrials: $2.04 Billion
Utilities: $1.82 Billion
Real Estate: $1.73 Billion
Other: $1.35 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 56
  • Current Value $210 Billion
  • Prior Value $275 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 15 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email